Effects of a Traditinal Chinese Medicine Compound Regimen on Differentiation and Proliferation of Acute Myeloid Leukemia Cell Lines.
10.19746/j.cnki.issn.1009-2137.2019.02.015
- Author:
Zhen-Ming SHEN
1
;
Bu-Xi ZHUANG
2
;
Yao ZHAO
3
;
Ming-Song WANG
4
;
Xin XU
3
;
Zhen-Bo HU
5
Author Information
1. Weifang Medical College, Weifang 261042，Shandong Province，China.
2. Institute of Shen Kang Hematology, Qinan 276300, Shandong Province, China.
3. Laboratory for Stem Cell and Regenerative Medicine，Affiliated Hospital of Weifang Medical College, Weifang 261042, Shandong Province, China.
4. Department of Traditional Chinese Medicine, Central Hospital of Linyi, Linyi 276000, Shandong Province, China.
5. Laboratory for Stem Cell and Regenerative Medicine，Affiliated Hospital of Weifang Medical College, Weifang 261042, Shandong Province, China,E-mail：zhenbohux@163.com.
- Publication Type:Journal Article
- MeSH:
Apoptosis;
Cell Differentiation;
Cell Proliferation;
HL-60 Cells;
Humans;
Leukemia, Myeloid, Acute
- From:
Journal of Experimental Hematology
2019;27(2):403-408
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To study the effect of traditional chinese medicine (TCM) compound on myeloid leukemia cells and to explore its anti-leukemic mechanism.
METHODS:Myeloid leukemia cell lines were cultured in vitro and treated with TCM compound. The proliferation of the leukemia cells was measured by CCK8 method. The differentiation of the leukemia cells was evaluated by using Wright＇s staining method and by light microscopy, and the expression of differentiation-related surface antigens such as CD11B was measured and by flow cytometry, the apoptosis of the leukemia cells was detected by flow cytometry with using Annexin V staining.
RESULTS:Compared with untreated 4 leukemia cell lines HL-60, MOLM-13, MV4-11, AML-M5, the proliferations of 4 leukemia cells treated with different concentrations of TCM compound decreased (P<0.05), and their proliferation inhibition were in a dose-dependent manner (r=0.9236; r=0.7488; r=0.8889; r=0.8119); compared with HL-60 and AML-M5 leukemia cells, the drug-treated 2 leukemia cells displayed obvious differentiated changes; compared with untreated HL-60 leukemia cell line, the expression of surface antigen CD11B increased by 85%±7.13% in HL-60 cells treated IC50 concentration of drug; compared with untreated AML-M5 leukemia cell line, the apoptotic rate of AML-M5 treated with 1.5 and 2 μl doses of TCM compound increased. (P<0.05).
CONCLUSION:The traditional chinese medicine compound may inhibit the proliferation of leukemia cell lines mainly by inducing leukemia cell differentiation and apoptosis.
